Comparative Pharmacology
Head-to-head clinical analysis: CHILDREN S ZYRTEC HIVES RELIEF versus PROMETHAZINE W CODEINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHILDREN S ZYRTEC HIVES RELIEF versus PROMETHAZINE W CODEINE.
CHILDREN'S ZYRTEC HIVES RELIEF vs PROMETHAZINE W/ CODEINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cetirizine is a second-generation antihistamine that selectively inhibits peripheral H1 receptors, reducing histamine-mediated allergic responses. It also inhibits eosinophil chemotaxis and mast cell mediator release.
Codeine is a prodrug converted to morphine, a mu-opioid receptor agonist, which inhibits nociceptive transmission; promethazine is a phenothiazine derivative with H1-receptor antagonism, anticholinergic, and antiemetic effects.
For adults, the recommended dose of cetirizine (active ingredient in Children's Zyrtec Hives Relief) is 10 mg orally once daily. Route: oral. Frequency: once daily.
10 mL (1 mg codeine, 6.25 mg promethazine per 5 mL) orally every 4-6 hours as needed for cough. Maximum: 60 mL per day. Do not exceed 5 days.
None Documented
None Documented
Terminal elimination half-life is 8-11 hours in healthy adults, allowing once-daily dosing. In renal impairment (CrCl <30 mL/min), half-life may increase to 20-30 hours requiring dose adjustment.
Promethazine: 10-19 hours (terminal). Codeine: 2.5-3.5 hours (terminal); prolonged in renal impairment.
Renal excretion accounts for approximately 70% of the administered dose, primarily as unchanged drug via tubular secretion. Fecal elimination is about 10% with the remainder metabolized.
Promethazine: renal (70% as metabolites, <1% unchanged), fecal (20-30%). Codeine: renal (90%, of which 5-10% unchanged, rest as metabolites), fecal (minor).
Category C
Category A/B
Antihistamine
Antihistamine / Antiemetic